Discover how automated assays are helping drive targeted protein degradation (TPD) research programs and Degrader development.
During this webinar, the Bio-Techne® team will be joined by Dr Gary Allenby, CSO at Aurelia Bioscience, who will delve deeper into how their research team is utilizing automated Western blot systems from ProteinSimple™, a Bio-Techne brand.
Find out how high-throughput Western blotting platforms Wes™ and Jess™ from ProteinSimple can be used to rapidly and reproducibly quantify protein knockdown following treatment with Degraders.
Find out how high-throughput Western blotting platforms Wes™ and Jess™ from ProteinSimple can be used to rapidly and reproducibly quantify protein knockdown following treatment with Degraders.
Speakers:
 |
Dr.
Gary Allenby CSO Aurelia Bioscience |
 |
Dr.
Hannah Maple Innovation Manager Tocris, a Bio-Techne brand |
 |
Dr.
Carsten Lück FAS and Science Manager, EMEA ProteinSimple, a Bio-Techne brand |
